What Is the Pulmonary Trunk and What Does It Do?

The pulmonary trunk is the large artery that carries oxygen-poor blood from the right ventricle of the heart toward the lungs, where it splits into the left and right pulmonary arteries. It is one of only two great vessels leaving the heart (the other being the aorta), yet it operates in a completely different pressure environment. Because it feeds a low-resistance circuit, the pulmonary trunk has thinner walls, lower pressures, and more stretch than its systemic counterpart, and those differences shape everything from how it forms in the womb to how it fails in disease.

Location and Spatial Relationships

The pulmonary trunk begins at the pulmonary valve, sitting just in front of and slightly to the left of the ascending aorta. It runs only about five centimeters before splitting into the left and right pulmonary arteries beneath the aortic arch. Despite its short length, the vessel is packed into a crowded neighborhood. The left coronary arteries, which supply the heart muscle itself, pass very close to the outer wall of the pulmonary trunk. In a study using automated three-dimensional distance measurements, the minimum distance between the pulmonary trunk and the nearest coronary artery averaged just 1.4 mm, with the closest point sitting roughly 14 mm above the pulmonary valve ring.¹ That proximity matters during catheter-based procedures inside the pulmonary trunk, where heat or pressure could injure a coronary artery sitting just millimeters away.

The study found that the most critical zone was the anterior face of the left cusp region. Within the first 10 mm above the left cusp, about 84% of patients had coronary arteries close enough to be at risk if a safety margin of 5 mm were applied. Between 10 and 20 mm above the left cusp, that figure climbed to 97%.² Positions near the right and anterior cusps were less dangerous. These measurements are not just academic; they guide electrophysiologists and interventional cardiologists when planning ablation procedures or device implantations near the pulmonary valve.

How the Pulmonary Trunk Forms Before Birth

Early in embryonic development, the heart starts out as a single tube. Blood exits this tube through a shared outflow vessel called the truncus arteriosus. For a normal heart to develop, that shared tube must split into two: the aorta and the pulmonary trunk. The partition responsible for this split is called the aorticopulmonary septum, and it depends heavily on a special group of migratory cells known as cardiac neural crest cells. These cells travel from the developing nervous system into the heart and differentiate into the smooth-muscle tissue that forms the septum itself.³

When neural crest migration fails, the truncus arteriosus never fully divides, resulting in a condition called persistent truncus arteriosus, where a single great vessel exits the heart and supplies both the lungs and the body. Studies in Splotch mutant mice, which carry defects in neural crest-derived cell populations, confirmed this link: homozygous mutant embryos consistently showed a failure of truncal septation.⁴ In humans, persistent truncus arteriosus is rare but serious, and it can run in families. A study of one family identified a novel variant in the GATA6 gene: the father had persistent truncus arteriosus, two of three children had the same defect, and the third had an atrial septal defect. The variant disrupted the zinc-finger domain of the GATA6 protein, impairing its ability to bind DNA and regulate the genes involved in outflow tract development.⁵

The Pulmonary Trunk in Fetal Life

Before a baby takes its first breath, the lungs are collapsed and filled with fluid, so there is no point in sending a large volume of blood through them. The fetus solves this problem with a short-circuit vessel called the ductus arteriosus, which connects the pulmonary trunk directly to the aorta. This shunt allows most of the blood pumped by the right ventricle into the pulmonary trunk to bypass the lungs entirely and flow straight into the systemic circulation.⁶

The distribution of blood between the lungs and the ductus is not static, though. In fetal lambs at baseline, about 83% of the blood flowing through the pulmonary trunk crossed the ductus arteriosus, while only 17% entered the lungs. Flow patterns shifted during each heartbeat: early in systole, a forward-running pressure wave actually directed more blood into the pulmonary arteries, but by mid-systole a backward-running wave from the lungs redirected flow into the ductus instead.⁷ At birth, as the lungs expand and pulmonary resistance plummets, this balance reverses almost immediately, and the ductus arteriosus normally closes within the first days of life.

Why It Operates at Low Pressure

After birth, the pulmonary trunk settles into its permanent role as the feeder vessel for a low-pressure, high-compliance circulation. While the aorta handles systolic pressures around 120 mmHg, the pulmonary trunk normally sees only about 25 mmHg at peak. The entire pulmonary arterial tree is built for this gentler environment: thinner walls, less smooth muscle, and more elastin relative to collagen, which allows the vessel to stretch easily with each heartbeat and then recoil. This compliance serves as a hydraulic buffer, smoothing the pulsatile output of the right ventricle into steadier flow through the lung capillaries.

When pulmonary pressures rise, that compliance is one of the first things to deteriorate. In pulmonary hypertension, increased collagen deposition stiffens the artery walls, forcing the right ventricle to work harder against both higher resistance and a less forgiving vessel.⁸ The loss of compliance is not just a passive consequence of rising pressures; it actively worsens the disease by increasing the pulsatile load on the right heart, creating a vicious cycle.

Normal Dimensions and What Enlargement Means

On a CT scan of the chest, the main pulmonary artery (the clinical name for the pulmonary trunk when measured on imaging) is one of the easiest large vessels to see and measure. Knowing what “normal” looks like matters because an enlarged pulmonary trunk can be an early sign that pressures inside it are too high. Data from the Framingham Heart Study established sex-specific reference values: the upper limit of normal is roughly 29 mm in men and 27 mm in women. Diameters above those thresholds were associated with a higher likelihood of reporting shortness of breath.⁹

Even before pressures cross the traditional threshold for pulmonary hypertension, the pulmonary trunk can start to widen. In symptomatic patients with borderline elevations in pulmonary pressure, the main pulmonary artery diameter was significantly larger than in those with normal pressures and correlated with both mean pulmonary artery pressure and pulmonary vascular resistance.¹⁰ Using a cutoff of 29 mm or greater, CT predicted borderline pulmonary hypertension with a sensitivity of 77% and a specificity of 62%.¹¹

In patients with chronic obstructive pulmonary disease, where pulmonary hypertension is common, the relationship between artery size and pressure was even clearer. Those with confirmed pulmonary hypertension had a mean pulmonary artery diameter of about 34 mm compared with 29 mm in those without.¹² The ratio of the pulmonary artery to the aorta (the PA:A ratio) also proved useful: a ratio above 1 suggested elevated pressures, and the correlation between this ratio and measured mean pulmonary artery pressure was strong.¹³ Radiologists now routinely flag a pulmonary trunk that looks bigger than the aorta on a standard chest CT, even when the scan was ordered for something else entirely.

Congenital Heart Defects Involving the Pulmonary Trunk

Beyond persistent truncus arteriosus, the pulmonary trunk plays a central role in tetralogy of Fallot, the most common cyanotic congenital heart defect. Tetralogy of Fallot involves four features: a ventricular septal defect, obstruction of the right ventricular outflow tract, an aorta that overrides the ventricular septum, and thickening of the right ventricle.¹⁴ In many affected individuals, the pulmonary trunk itself is narrowed (hypoplastic), compounding the obstruction. Classic anatomic studies noted that hypoplasia of the pulmonary trunk was more closely linked to stenosis at the pulmonary valve than to narrowing of the muscular infundibulum below it.¹⁵

Imaging studies have confirmed a tight relationship between pulmonary valve shape and the caliber of the pulmonary trunk in tetralogy of Fallot patients. There is a statistically significant association between valve morphology and the size of the pulmonary trunk, as well as between valve morphology and the degree of infundibular hypoplasia.¹⁶ This matters for surgical planning: a severely hypoplastic pulmonary trunk may need patch augmentation or reconstruction at the time of repair, rather than simple relief of the valve obstruction alone.

Vortex Flow and Advanced Imaging

Standard imaging can measure the pulmonary trunk’s diameter and estimate pressures, but newer techniques are beginning to capture the actual behavior of blood flowing through it. Four-dimensional flow MRI (4D flow CMR) tracks velocity in three dimensions over the cardiac cycle, revealing swirling patterns inside the pulmonary trunk that are invisible on conventional scans. In a pilot study of patients with pulmonary hypertension, vortical flow in the main pulmonary artery was quantified using a metric called circulation. This metric distinguished patients with pulmonary hypertension from healthy controls and correlated strongly with invasive markers of disease severity.¹⁷

Similar techniques have been applied to patients with chronic thromboembolic pulmonary hypertension, a form of the disease caused by old blood clots that never fully dissolved. In these patients, the duration and area of backward flow in the pulmonary trunk, which reflects vortex formation, were evaluated before and after balloon pulmonary angioplasty, a catheter-based treatment that opens up blocked vessels.¹⁸ The potential of vortex metrics as non-invasive biomarkers for monitoring treatment response is an active area of research, though these tools are not yet part of routine clinical practice.

Nerve Supply and Baroreceptors

The pulmonary trunk is not just a passive conduit. Its walls contain sensory nerve endings, including baroreceptors that detect changes in stretch and pressure. When pulmonary artery pressure rises, these receptors fire and trigger a reflex response: sympathetic outflow increases, systemic blood vessels constrict, and respiratory drive ramps up.¹⁹ This pulmonary baroreflex was first demonstrated convincingly in anesthetized animals, where directly stimulating pulmonary artery baroreceptors caused a measurable increase in sympathetic nerve activity.²⁰

The sympathetic nerves running along the outside of the pulmonary trunk have also attracted therapeutic interest. Researchers have found clusters of sympathetic nerve bundles in the connective tissue surrounding the main pulmonary artery trunk and its bifurcation, both in rats and in samples from human heart-transplant patients. In an animal model of pulmonary arterial hypertension, denervating these nerves (a procedure called transthoracic pulmonary artery denervation) lowered mean pulmonary artery pressures, reduced remodeling of the pulmonary arteries and right ventricle, and improved right-heart function.²¹ The mechanism appeared to involve dampening of the sympathetic nervous system and the renin-angiotensin-aldosterone hormonal axis. Whether this translates into a viable treatment for human pulmonary hypertension is still being investigated.

Drug Targets in the Pulmonary Trunk Wall

The smooth muscle cells in the pulmonary trunk and its branches are the direct targets of most current pulmonary hypertension therapies. These drugs work by relaxing that muscle through several different molecular pathways. Prostaglandins, phosphodiesterase inhibitors, guanylate cyclase stimulators, endothelin receptor antagonists, inhaled nitric oxide, and Rho kinase inhibitors all decrease the contractile tone of pulmonary vascular smooth muscle, thereby lowering pulmonary vascular resistance.²² Most patients with significant disease are placed on combination therapy, using drugs from two or three of these classes simultaneously.

Beyond the usual suspects, statins have shown an unexpected ability to relax pulmonary arteries. In laboratory experiments, simvastatin suppressed contractions triggered by multiple different stimuli by roughly half, and it relaxed hypertensive arteries even when no contracting agent was present. The effect did not depend on the inner lining of the artery (the endothelium), meaning the drug acted directly on the smooth muscle. The mechanism appeared to involve blocking Rho kinase (ROCK) pathways and calcium channels.²³ Statins are not approved for pulmonary hypertension, and clinical trials in humans have produced mixed results, but the finding illustrates how pharmacology keeps uncovering new ways to influence the pulmonary trunk’s behavior.

Surgical and Catheter-Based Repairs

Several congenital heart repairs require direct reconstruction of the pulmonary trunk or the valve at its base. In the arterial switch operation, used to correct transposition of the great arteries, the pulmonary trunk and aorta are physically detached and reconnected to the correct ventricles. One of the long-term complications of this operation is narrowing (stenosis) of the new pulmonary artery connection. Using an extended pericardial patch to augment the neo-pulmonary root and trunk at the time of surgery has been shown to lower the rate of late pulmonary artery stenosis compared with other techniques described in the literature.²⁴

For patients who already have a dysfunctional right ventricular outflow tract, whether from a previous surgery or from a congenital conduit, percutaneous pulmonary valve implantation offers a way to replace the pulmonary valve without open-heart surgery. A catheter delivers a valve stent through a vein and positions it at the pulmonary trunk. The procedure has been shown to be safe and effective for both pulmonary valve insufficiency and stenotic outflow tracts.²⁵ It has even been performed successfully in small children weighing under 30 kg, where the peak pressure gradient across the conduit dropped from an average of 29 mmHg before the procedure to 9 mmHg afterward, and severe regurgitation was essentially eliminated in the short term.²⁶

Aneurysms of the Pulmonary Trunk

Aneurysms (true bulging of the artery wall) and pseudoaneurysms (contained ruptures through the wall) of the pulmonary trunk are uncommon but carry serious risks. The most frequent causes in adults are trauma (often from medical procedures), infection, and Behçet’s syndrome, an inflammatory condition that attacks blood vessel walls. Less common causes include longstanding pulmonary hypertension, congenital heart disease, tumors, and connective tissue disorders.²⁷ Rupture of a pulmonary artery aneurysm is a life-threatening event, so recognizing the widened vessel on imaging before it ruptures is important. On a plain chest X-ray, a prominent bulge at the left heart border may be the first clue. CT angiography confirms the diagnosis and defines the anatomy well enough for surgical planning. Some small, stable aneurysms can be monitored, but larger or rapidly growing ones typically require intervention, either open repair or catheter-based techniques depending on the location and the patient’s overall condition.